HealthEquity Inc. (HQY) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
HealthEquity Inc. (HQY) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How HQY Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $1.31B | 69.5% | 24.6% | $215.2M | $455.1M | 9.3% |
| FY 2024 | $1.20B | 64.8% | 13.5% | $96.7M | $337.8M | 4.5% |
| FY 2023 | $999.6M | 44% | 11.8% | $55.7M | $197.8M | 3.3% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring HQY)
- ✓Live walkthrough of HQY's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
HQY Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HQY today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HQY. Explore sector supply chains on /butterfly.
HQY Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is HealthEquity Inc. (HQY)?
In FY 2025 (10-K), HQY converted $1.3B of revenue into a 69.5% gross margin, 24.6% operating margin, and $455.1M in free cash flow (34.7% FCF margin).